Cyanocobalamin is primarily prescribed for vitamin B12 deficiency, which can occur due to a variety of conditions such as pernicious anemia, prolonged use of certain medications, surgery in the gastrointestinal tract or dietary deficiencies
Since 2001, many clinical trials have been conducted on omnivores to see if lowering homocysteine through pharmacological doses of folate, B12, and sometimes vitamin B6, could reduce the risk of cardiovascular disease, premature death, and cognitive decline
Clinical correlation remains essential when interpreting laboratory findings
As I said, I think that's an open question, but open to hearing about any research which would shed light on that
It is described as an ERR// agonist chemical tool, with the highest reported potency for ERR